首页> 外文期刊>Journal of Labelled Compounds and Radiopharmaceuticals >Detailed evaluation of different Ge-68/Ga-68 generators: an attempt toward achieving efficient Ga-68 radiopharmacy
【24h】

Detailed evaluation of different Ge-68/Ga-68 generators: an attempt toward achieving efficient Ga-68 radiopharmacy

机译:对不同的Ge-68 / Ga-68发生器的详细评估:尝试实现高效的Ga-68放射性药物

获取原文
获取原文并翻译 | 示例
           

摘要

The present study is aimed at carrying out a comparative performance evaluation of different types of Ge-68/Ga-68 generators to identify the best choice for use in Ga-68-radiopharmacy. Over the 1year period of evaluation, the elution yields from the CeO2-based and SiO2-based Ge-68/Ga-68 generators remained almost consistent, in contrast to the sharp decrease observed in the elution yields from TiO2 and SnO2-based generators. The level of Ge-68 impurity in Ga-68 eluates from the CeO2 and SiO2-based Ge-68/Ga-68 generator was always <10(-3)%, while this level increased from 10(-3)% to 10(-1)% in case of TiO2 and SnO2-based generators. The level of chemical impurities in Ga-68 eluates from CeO2 and SiO2-based Ge-68/Ga-68 generators was negligibly low (<0.1ppm) in contrast to the significantly higher level (1-20ppm) of such impurities in eluates from other two generators. As demonstrated by radiolabeling studies carried out using DOTA-coupled dimeric cyclic RGD peptide derivative (DOTA-RGD(2)), CeO2-PAN and SiO2-based generators are directly amenable for radiopharmaceutical preparation, whereas the other generators can be only used after post-elution purification of Ga-68 eluates. Clinically relevant dose of Ga-68-DOTA-RGD(2) was prepared in a hospital radiopharmacy for non-invasive visualization of tumors in breast cancer patients using positron emission tomography.
机译:本研究旨在对不同类型的Ge-68 / Ga-68发生器进行比较性能评估,以确定在Ga-68-放射药物中使用的最佳选择。在1年的评估期内,CeO2基和SiO2基Ge-68 / Ga-68发生器的洗脱产率几乎保持一致,而TiO2和SnO2发生器的洗脱产率却急剧下降。来自CeO2和SiO2的Ge-68 / Ga-68发生器的Ga-68洗出液中Ge-68杂质的水平始终<10(-3)%,而该水平从10(-3)%增加到10对于TiO2和SnO2基发生器,为(-1)%。来自CeO2和SiO2的Ge-68 / Ga-68发生器的Ga-68洗出液中的化学杂质含量低至可以忽略不计(<0.1ppm),而来自这些样品的洗出液中此类杂质的含量明显更高(1-20ppm)其他两个发电机。正如使用DOTA偶联二聚环RGD肽衍生物(DOTA-RGD(2))进行的放射性标记研究所证明的那样,基于CeO2-PAN和SiO2的生成器可直接用于放射性药物制备,而其他生成器只能在后期处理后使用-68 Ga-洗脱液的纯化。临床相关剂量的Ga-68-DOTA-RGD(2)是在一家医院的放射药房中准备的,用于使用正电子发射断层扫描术对乳腺癌患者的肿瘤进行非侵入性可视化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号